Lord, Abbett & Co
LOXO

Lord, Abbett & Co’s Loxo Oncology, Inc LOXO Stock Holding History

Lord, Abbett & Co’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-221,673
Closed -$31.1M – 829
2018
Q4 		$31.1M Sell
221,673
-362,395
-62% -$55M 0.11% 279
2018
Q3 		$99.8M Buy
584,068
+45,726
+8% +$7.68M 0.28% 84
2018
Q2 		$93.4M Sell
538,342
-128,429
-19% -$19.3M 0.27% 96
2018
Q1 		$76.9M Buy
666,771
+114,963
+21% +$12.2M 0.23% 117
2017
Q4 		$46.5M Sell
551,808
-205,568
-27% -$17.1M 0.13% 252
2017
Q3 		$69.8M Buy
757,376
+17,836
+2% +$1.39M 0.2% 140
2017
Q2 		$59.3M Buy
739,540
+582,862
+372% +$32.3M 0.18% 179
2017
Q1 		$6.59M Buy
+156,678
New +$6.45M 0.02% 698

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Lord, Abbett & Co's LOXO Position: Q1 2019 in Review

Lord, Abbett & Co sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 221,673 shares — an estimated $31.1M sold.

Lord, Abbett & Co first reported a position in LOXO in Q1 2017 and held it in 8 quarters. The position peaked at $99.8M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Lord, Abbett & Co reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 221,673 Loxo Oncology, Inc shares in Q1 2019, an estimated $31.1M.
  • Lord, Abbett & Co first reported a position in Loxo Oncology, Inc in Q1 2017 and held it in 8 quarters.
  • Lord, Abbett & Co's Loxo Oncology, Inc position peaked at $99.8M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.